323 results
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
9 May 24
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
7:00am
and health benefits of breastfeeding should be considered along with the mother’s clinical need for Galafold and any potential adverse effects
8-K
EX-99.1
0vc5o723fdtqt 8s71
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
8-K
EX-99.1
g6dyf6a2
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
S-3ASR
4vwxciu
8 Nov 23
Automatic shelf registration
5:25pm
8-K
EX-99.1
4hicvaf8 n9pn
8 Nov 23
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
mygh1pbg42s4bd0
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-10.2
37w nojzyjdmd
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-99.1
4tm9rd72wfga71paxmt9
27 Sep 23
AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Corporate Overview September 2023
7:00am
8-K
EX-99.1
84qucf16b jeayyk
15 Aug 23
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
7:00am
8-K
EX-99.1
e8oenuo2
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
xbd 4tvxcmz5q3llcyqb
13 Jul 23
Departure of Directors or Certain Officers
5:00pm